Development and Evaluation of Nefopam Transdermal Matrix Patch System in Human Volunteers

References

1. 1.↵
   1. Mukherjee B.,
   2. Mahapatra S.,
   3. Gupta R.,
   4. Patra B.,
   5. Tiwari A.,
   6. Arora P.

   A comparison between povidone-ethylcellulose and providone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation. Eur. J. Pharm. Biopharm. 2005, 59 ( 3), 475– 483

   OpenUrlPubMed
2. 2.↵
   1. Jain N. K.

   1. Misra A. N.

   Transdermal Drug Delivery. In Controlled and Novel Drug Delivery; Jain N. K., Ed.; Varghese Publication: New Delhi, 1988; pp 100– 129.
3. 3.↵
   1. Mukherjee B.,
   2. Das S.,
   3. Patra B.,
   4. Layek B.

   Nefopam containing transdermal-matrix patches based on pressure-sensitive adhesive polymers. Pharmaceutical Technology (USA) 2006, 30 ( 3), 146– 163.

   OpenUrl
4. 4.↵
   1. Aymard G.,
   2. Warot D.,
   3. Demolis P.,
   4. Giudicelli J. F.,
   5. Lechat P.,
   6. Le Guern M. E.,
   7. Alquier C.,
   8. Diquet B.

   Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers. Pharmacol. Toxicol. 2003, 92 ( 6), 279– 286

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Fuller R. W.,
   2. Snoddy H. D.

   Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice. Neuropharmacology 1993, 32 ( 10), 995– 999

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Heel R. C.

   Nefopam: A review of its pharmacological properties and therapeutic efficacy. Drugs 1980, 19 ( 4), 249– 267

   OpenUrlPubMedWeb of Science
7. 7.↵
   1. Arora P.,
   2. Mukherjee B.

   Design, development, physiochemical, and in vitro evaluation of transdemal patches containing diclofenac diethylammonium salt. J. Pharm. Sci. 2002, 91 ( 9), 2076– 2089

   OpenUrlPubMed
8. 8.↵
   1. Mutalik S.,
   2. Udupa N.

   Glibenclamide transdermal patches patches: Physicochemical, pharmacodynamic and pharmacokinetic evaluations. J. Pharm. Sci. 2004, 93 ( 6), 1577– 1594

   OpenUrlPubMed
9. 9.↵
   1. Thomas N. S.,
   2. Panchagula R.

   Transdermal delivery of zidovudine: Effect of vehicles on permeation across rat skin and their mechanism of action.. Eur. J. Pharm. Sci. 2003, 18 ( 1), 71– 79

   OpenUrlPubMed
10. 10.↵
    1. Pequignot A.,
    2. Tumosa C. S.,
    3. von Endt D. W.

    The effect of tanning and fixing processes of the properties of taxidermy skins. Collection Forum 2006, 21 ( 1–2) 133– 142.

    OpenUrl
11. 11.↵
    1. Hood B. L.,
    2. Conrads T. P.,
    3. Veenstra T. D.

    Unravelling the proteome of formalin-fixed paraffin-embedded tissue. Briefings in Functional Genomics Proteomics 2006, 5 ( 2), 169– 175

    OpenUrlPubMed
12. 12.↵
    www.scienceinthebox.com/en_UK/safety/skinirritation_en.html. Accessed, on March 27, 2003.
13. 13.↵
    1. Aymard G.,
    2. Warot D.,
    3. Demolis P.,
    4. Laville I.,
    5. Diquet B.

    Sensitive determination of nefopam and its metabolite desmethyl-nefopam in human biological fluid by HPLC. J. Pharm. Biomed. Anal. 2002, 30 ( 4), 1013– 1021

    OpenUrlPubMed
14. 14.↵
    1. Chang L.,
    2. Wang D.

    Rapid fluorimetric assay for plasma nefopam using high-performance liquid chromatography. J. Liq. Chromatogr. 1994, 17 ( 9), 1971– 1980

    OpenUrl
15. 15.↵
    1. Katayose S.,
    2. Kataoka K.

    Water soluble polyion complex associates of DNA and poly (ethylene glycol)-poly (L-Lysin) block copolymers. Bioconjugate Chem. 1997, 8 ( 5), 702– 707.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Anderson D. T.,
    2. Muto J. J.

    Duragesic transdermal patch: Postmortem tissue distribution of fentanyl in 25 cases. J. Anal. Toxicol. 2000, 24 ( 7), 627– 34

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Bodmeier R.,
    2. Paeratakul O.

    Drug release from laminated polymeric films prepared from aqueous latexes. J. Pharm. Sci. 1990, 79 ( 10), 32– 36

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Fan L. T.,
    2. Singh S. K.

    Controlled Release: A Quantitative Treatment. Spinger-Verlag: New York, 1989; pp 13– 129.
19. 19.↵
    1. Kotting C.,
    2. Gerwert K.

    Monitoring protein ligand interactions by time resolved FTIR difference spectroscopy. Methods Mol. Biol. 2005, 305, 261– 286

    OpenUrlPubMed
20. 20.↵
    1. Robinson J. R.,
    2. Lee V. H. L.

    1. Chien Y. W.

    Transdermal Therapeutic System In; Controlled Drug Delivery: Fundamentals and Applications. Robinson J. R., Lee V. H. L. Eds.; Marcel Dekker: New York, 1987; 524– 552.
21. 21.↵
    1. Johnson M. E.,
    2. Blankschtein D.,
    3. Langer R.

    Evaluation of solute permeation through the stratum corneum: Lateral bilayer diffusion as the primary transport mechanism. J. Pharm. Sci. 1997, 86 ( 10), 1162– 1172

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Martin A.,
    2. Bustamante P.,
    3. Chun A. H. C.

    Physical Pharmacy; B. I. Waverly Private Limited: New Delhi, India, 1999; pp 284– 323.
23. 23.↵
    www.tiaft.org (as reported by the International Association of Forensic Toxicologists in its web site mentioned here). Accessed November 12, 2004.